Trial Outcomes & Findings for Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy (NCT NCT00526331)
NCT ID: NCT00526331
Last Updated: 2012-01-16
Results Overview
Length of hospital stay of arterial pressure-based cardiac output (APCO) monitor participants versus the participants using the global standard care guided by esophageal Doppler, measured in days.
COMPLETED
PHASE4
49 participants
From baseline (first day of hospital stay) to release from hospital (anticipate 5 days minimally)
2012-01-16
Participant Flow
Recruitment Period of August 8, 2007 to June 30, 2008 at UT MD Anderson Cancer Center. Study recruitment done at medical clinics.
Study terminated by sponsor responsible for multi-center data collection and reporting. No data collection or analysis completed.
Participant milestones
| Measure |
Overall Study
Study Group: FloTrac Sensor + Vigileo Monitor used to decide how much fluid to give during surgery; and Control Group: FloTrac Sensor + Vigileo Monitor only used for data collection during surgery while Standard of Care used to decide fluid amount.
|
|---|---|
|
Overall Study
STARTED
|
55
|
|
Overall Study
COMPLETED
|
0
|
|
Overall Study
NOT COMPLETED
|
55
|
Reasons for withdrawal
| Measure |
Overall Study
Study Group: FloTrac Sensor + Vigileo Monitor used to decide how much fluid to give during surgery; and Control Group: FloTrac Sensor + Vigileo Monitor only used for data collection during surgery while Standard of Care used to decide fluid amount.
|
|---|---|
|
Overall Study
Sponsor Termination
|
55
|
Baseline Characteristics
Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy
Baseline characteristics by cohort
| Measure |
Overall Study
n=55 Participants
Study Group: FloTrac Sensor + Vigileo Monitor used to decide how much fluid to give during surgery; and Control Group: FloTrac Sensor + Vigileo Monitor only used for data collection during surgery while Standard of Care used to decide fluid amount.
|
|---|---|
|
Age Continuous
|
62 years
n=5 Participants
|
|
Sex: Female, Male
Female
|
19 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
36 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
55 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: From baseline (first day of hospital stay) to release from hospital (anticipate 5 days minimally)Population: Study terminated by sponsor without analysis due to technical reasons.
Length of hospital stay of arterial pressure-based cardiac output (APCO) monitor participants versus the participants using the global standard care guided by esophageal Doppler, measured in days.
Outcome measures
Outcome data not reported
Adverse Events
Overall Study
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place